The economic burden of chronic obstructive pulmonary disease in the Asia-Pacific region : a systematic review
Background: Chronic obstructive pulmonary disease (COPD) is a significant and disabling condition that entails high economic burden for society. Objective:The aim of this article is to assess cost studies of COPD and analyze cross-country cost comparisons in Asia-Pacific. Methods:A systematic litera...
| Main Authors: | , , |
|---|---|
| Other Authors: | |
| Format: | Journal Article |
| Language: | English |
| Published: |
2020
|
| Subjects: | |
| Online Access: | https://hdl.handle.net/10356/143843 |
| _version_ | 1826129810495111168 |
|---|---|
| author | Woo, Lai Leng Smith, Helen Elizabeth Sullivan, Sean D. |
| author2 | Lee Kong Chian School of Medicine (LKCMedicine) |
| author_facet | Lee Kong Chian School of Medicine (LKCMedicine) Woo, Lai Leng Smith, Helen Elizabeth Sullivan, Sean D. |
| author_sort | Woo, Lai Leng |
| collection | NTU |
| description | Background: Chronic obstructive pulmonary disease (COPD) is a significant and disabling condition that entails high economic burden for society. Objective:The aim of this article is to assess cost studies of COPD and analyze cross-country cost comparisons in Asia-Pacific. Methods:A systematic literature search from October 2000 to October 2018 was conducted using PubMed, MEDLINE, and EMBASE to identify relevant studies. Costs reported by the different studies were converted to 2017 US dollars using the consumer price index for medical care. The quality of the studies was assessed using the Consolidated Health Economic Evaluation Reporting Standards.Results:Ten studies (6 countries and 11 estimates) were identified and included for full review after consideration of the inclusion and exclusion criteria. Annual total societal costs of COPD ranged from $4398 to $23 049 per capita in Japan and $453 to $12 167 in South Korea. There were no intracountry comparison estimates for the remaining countries (Singapore: $2700; Taiwan: $4000; China: $3942; and Thailand: $1105). In addition, there were estimates of partial costs in Singapore and Taiwan.Conclusions:Results of this review showed high cost variations between countries, with estimates in 2 countries (Japan and South Korea) exceeding those in UK and USA. Wide variation in disease cost estimates will continue to exist as long as there are differences in cost methodologies, disease severities included, and data limitation. We propose that researchers conducting burden-of-illness studies use standard methods and reporting formats to support cross-country comparisons. |
| first_indexed | 2024-10-01T07:46:37Z |
| format | Journal Article |
| id | ntu-10356/143843 |
| institution | Nanyang Technological University |
| language | English |
| last_indexed | 2024-10-01T07:46:37Z |
| publishDate | 2020 |
| record_format | dspace |
| spelling | ntu-10356/1438432020-11-01T05:29:07Z The economic burden of chronic obstructive pulmonary disease in the Asia-Pacific region : a systematic review Woo, Lai Leng Smith, Helen Elizabeth Sullivan, Sean D. Lee Kong Chian School of Medicine (LKCMedicine) Science::Medicine Asia-Pacific Chronic Obstructive Background: Chronic obstructive pulmonary disease (COPD) is a significant and disabling condition that entails high economic burden for society. Objective:The aim of this article is to assess cost studies of COPD and analyze cross-country cost comparisons in Asia-Pacific. Methods:A systematic literature search from October 2000 to October 2018 was conducted using PubMed, MEDLINE, and EMBASE to identify relevant studies. Costs reported by the different studies were converted to 2017 US dollars using the consumer price index for medical care. The quality of the studies was assessed using the Consolidated Health Economic Evaluation Reporting Standards.Results:Ten studies (6 countries and 11 estimates) were identified and included for full review after consideration of the inclusion and exclusion criteria. Annual total societal costs of COPD ranged from $4398 to $23 049 per capita in Japan and $453 to $12 167 in South Korea. There were no intracountry comparison estimates for the remaining countries (Singapore: $2700; Taiwan: $4000; China: $3942; and Thailand: $1105). In addition, there were estimates of partial costs in Singapore and Taiwan.Conclusions:Results of this review showed high cost variations between countries, with estimates in 2 countries (Japan and South Korea) exceeding those in UK and USA. Wide variation in disease cost estimates will continue to exist as long as there are differences in cost methodologies, disease severities included, and data limitation. We propose that researchers conducting burden-of-illness studies use standard methods and reporting formats to support cross-country comparisons. Accepted version 2020-09-25T07:55:58Z 2020-09-25T07:55:58Z 2019 Journal Article Woo, L. L., Smith, H. E., & Sullivan, S. D. (2019). The Economic Burden of Chronic Obstructive Pulmonary Disease in the Asia-Pacific Region: A Systematic Review. Value in Health Regional Issues, 18, 121–131. doi:10.1016/j.vhri.2019.02.002 2212-1102 https://hdl.handle.net/10356/143843 10.1016/j.vhri.2019.02.002 31051330 18 121 131 en Value in health regional issues © 2019 ISPOR. All rights reserved. This paper was published by Elsevier Inc in Value in health regional issues and is made available with permission of ISPOR. application/pdf |
| spellingShingle | Science::Medicine Asia-Pacific Chronic Obstructive Woo, Lai Leng Smith, Helen Elizabeth Sullivan, Sean D. The economic burden of chronic obstructive pulmonary disease in the Asia-Pacific region : a systematic review |
| title | The economic burden of chronic obstructive pulmonary disease in the Asia-Pacific region : a systematic review |
| title_full | The economic burden of chronic obstructive pulmonary disease in the Asia-Pacific region : a systematic review |
| title_fullStr | The economic burden of chronic obstructive pulmonary disease in the Asia-Pacific region : a systematic review |
| title_full_unstemmed | The economic burden of chronic obstructive pulmonary disease in the Asia-Pacific region : a systematic review |
| title_short | The economic burden of chronic obstructive pulmonary disease in the Asia-Pacific region : a systematic review |
| title_sort | economic burden of chronic obstructive pulmonary disease in the asia pacific region a systematic review |
| topic | Science::Medicine Asia-Pacific Chronic Obstructive |
| url | https://hdl.handle.net/10356/143843 |
| work_keys_str_mv | AT woolaileng theeconomicburdenofchronicobstructivepulmonarydiseaseintheasiapacificregionasystematicreview AT smithhelenelizabeth theeconomicburdenofchronicobstructivepulmonarydiseaseintheasiapacificregionasystematicreview AT sullivanseand theeconomicburdenofchronicobstructivepulmonarydiseaseintheasiapacificregionasystematicreview AT woolaileng economicburdenofchronicobstructivepulmonarydiseaseintheasiapacificregionasystematicreview AT smithhelenelizabeth economicburdenofchronicobstructivepulmonarydiseaseintheasiapacificregionasystematicreview AT sullivanseand economicburdenofchronicobstructivepulmonarydiseaseintheasiapacificregionasystematicreview |